TLSI
TriSalus Life Sciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.00
+0.40%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+60.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 6, 2026 | Patience David · officer: Chief Financial Officer | F-InKind | 14,650 | $4.46 |
| Jul 1, 2026 | Szela Mary T · director, officer: CEO and President | A-Award | 3,990 | $3.87 |
| Jul 1, 2026 | Marshak Richard · officer: Chief Commercial Officer | A-Award | 561 | $3.87 |
| Jun 29, 2026 | Marshall Richard Henry · officer: Chief Medical Officer | A-Award | 60,000 | $0.00 |
| Jun 29, 2026 | Marshall Richard Henry · officer: Chief Medical Officer | A-Award | 120,000 | $4.74 |
| May 19, 2026 | Marshak Richard · officer: Chief Commercial Officer | Sale | 543 | $2.67 |
| May 18, 2026 | Gordon Gary B. · director | Purchase | 10,000 | $2.46 |
| May 18, 2026 | Wahlstrom Mats · director | Purchase | 60,000 | $2.53 |
| May 18, 2026 | Stansky Michael P · director | Purchase | 410,000 | $2.50 |
| May 18, 2026 | Stansky Michael P · director | Purchase | 200,000 | $2.50 |
| May 18, 2026 | Szela Mary T · director, officer: CEO and President | Purchase | 39,682 | $2.59 |
| May 18, 2026 | Patience David · officer: Chief Financial Officer | Purchase | 7,100 | $2.43 |
| May 15, 2026 | Valle William · director | A-Award | 28,201 | $0.00 |
| May 15, 2026 | Valle William · director | A-Award | 24,553 | $0.00 |
| May 15, 2026 | Valle William · director | A-Award | 56,403 | $2.52 |
| May 15, 2026 | Stansky Michael P · director | A-Award | 23,501 | $0.00 |
| May 15, 2026 | Stansky Michael P · director | A-Award | 20,089 | $0.00 |
| May 15, 2026 | Stansky Michael P · director | A-Award | 47,003 | $2.52 |
| May 15, 2026 | Wahlstrom Mats · director | A-Award | 75,204 | $2.52 |
| May 15, 2026 | Wahlstrom Mats · director | A-Award | 34,226 | $0.00 |
| May 15, 2026 | Wahlstrom Mats · director | A-Award | 37,602 | $0.00 |
| May 15, 2026 | HICKS KERRY R · director | A-Award | 56,403 | $2.52 |
| May 15, 2026 | Gordon Gary B. · director | A-Award | 28,201 | $0.00 |
| May 15, 2026 | HICKS KERRY R · director | A-Award | 28,201 | $0.00 |
| May 15, 2026 | Gordon Gary B. · director | A-Award | 24,553 | $0.00 |
| May 15, 2026 | Gordon Gary B. · director | A-Award | 56,403 | $2.52 |
| May 15, 2026 | MATLIN DAVID J · director | A-Award | 28,201 | $0.00 |
| May 15, 2026 | MATLIN DAVID J · director | A-Award | 23,065 | $0.00 |
| May 15, 2026 | MATLIN DAVID J · director | A-Award | 56,403 | $2.52 |
| Mar 20, 2026 | Devlin Jodi · officer: Chief of Clinical Operations | Sale | 1,772 | $4.09 |
Institutional positioning
13F filings over the trailing two quarters
New 33Increased 21Reduced 17Sold out 83
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FIRST LIGHT ASSET MANAGEMENT, LLC | New Position | 5,066,827 | May 15, 2026 |
| AWM INVESTMENT COMPANY, INC. | Increased | 2,079,105 | May 15, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | Unchanged | 2,070,827 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 1,499,547 | May 13, 2026 |
| WASATCH ADVISORS LP | New Position | 1,437,960 | Apr 21, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,347,036 | May 15, 2026 |
| GILDER GAGNON HOWE & CO LLC | Reduced | 888,515 | May 15, 2026 |
| CERITY PARTNERS LLC | New Position | 787,272 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 777,094 | May 15, 2026 |
| THOMPSON SIEGEL & WALMSLEY LLC | New Position | 583,574 | May 11, 2026 |
| KENNEDY CAPITAL MANAGEMENT LLC | New Position | 485,242 | May 13, 2026 |
| MORGAN STANLEY | Reduced | 393,909 | May 15, 2026 |
| STATE STREET CORP | Increased | 328,020 | May 15, 2026 |
| EMPIRE FINANCIAL MANAGEMENT COMPANY, LLC | Increased | 300,275 | May 18, 2026 |
| PERKINS CAPITAL MANAGEMENT INC | New Position | 230,101 | Apr 23, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 6, 2026